Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,600 | 15 | 85.7% |
| Food and Beverage | $4,706 | 264 | 14.1% |
| Education | $31.22 | 2 | 0.1% |
| Gift | $15.94 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $29,018 | 39 | $0 (2020) |
| ABBVIE INC. | $1,971 | 102 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $637.20 | 47 | $0 (2024) |
| Celgene Corporation | $255.96 | 16 | $0 (2024) |
| Ardelyx, Inc. | $214.38 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $187.60 | 11 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $116.98 | 7 | $0 (2020) |
| Gilead Sciences, Inc. | $96.34 | 4 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $77.11 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $74.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,395 | 78 | ABBVIE INC. ($781.37) |
| 2023 | $1,202 | 63 | AbbVie Inc. ($529.80) |
| 2022 | $849.83 | 46 | ABBVIE INC. ($392.46) |
| 2021 | $164.22 | 10 | AbbVie Inc. ($148.77) |
| 2020 | $6,705 | 20 | Allergan, Inc. ($6,553) |
| 2019 | $8,928 | 45 | Allergan Inc. ($8,502) |
| 2018 | $13,991 | 19 | Allergan Inc. ($13,847) |
| 2017 | $117.10 | 1 | Allergan Inc. ($117.10) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.96 | General |
| 12/18/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: VIROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.03 | General |
| 09/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Immunology | ||||||
| 08/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 657 | 674 | $286,425 | $64,070 |
| 2022 | 13 | 608 | 636 | $292,525 | $58,573 |
| 2021 | 13 | 623 | 662 | $248,610 | $56,334 |
| 2020 | 11 | 680 | 729 | $289,165 | $71,508 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 79 | 79 | $49,000 | $12,948 | 26.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 131 | 137 | $72,480 | $10,225 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 131 | 141 | $42,840 | $9,877 | 23.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 69 | 69 | $30,925 | $8,314 | 26.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 26 | 26 | $15,700 | $4,406 | 28.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 23 | 23 | $14,115 | $3,902 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 85 | 86 | $18,040 | $3,412 | 18.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $12,220 | $3,359 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $11,015 | $2,599 | 23.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $5,990 | $1,702 | 28.4% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $5,640 | $1,547 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 23 | 23 | $6,095 | $1,192 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,365 | $587.61 | 24.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 126 | 137 | $71,925 | $10,371 | 14.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 61 | 61 | $42,700 | $10,294 | 24.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 57 | 57 | $57,000 | $9,051 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 90 | 95 | $23,750 | $5,671 | 23.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $27,125 | $4,702 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 103 | 113 | $14,125 | $4,501 | 31.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $22,400 | $3,918 | 17.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 14 | 14 | $9,800 | $2,412 | 24.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $6,300 | $2,131 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $6,300 | $1,695 | 26.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $3,250 | $1,655 | 50.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 28 | 28 | $5,600 | $1,370 | 24.5% |
About Dr. Thomas Young, MD
Dr. Thomas Young, MD is a Gastroenterology healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053493791.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Young, MD has received a total of $33,354 in payments from pharmaceutical and medical device companies, with $1,395 received in 2024. These payments were reported across 282 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,600).
As a Medicare-enrolled provider, Young has provided services to 2,568 Medicare beneficiaries, totaling 2,701 services with total Medicare billing of $250,486. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Knoxville, TN
- Active Since 10/20/2006
- Last Updated 04/28/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053493791
Products in Payments
- LINZESS (Drug) $29,166
- SKYRIZI (Biological) $633.60
- XIFAXAN (Drug) $539.85
- RINVOQ (Biological) $508.13
- MAVYRET (Drug) $214.40
- IBSRELA (Drug) $214.38
- ZEPOSIA (Drug) $207.75
- ENTYVIO (Biological) $168.55
- ZENPEP (Drug) $125.61
- CREON (Drug) $118.48
- Linzess (Drug) $116.98
- HUMIRA (Biological) $109.06
- DOPTELET (Drug) $89.51
- VIBERZI (Drug) $79.75
- DIFICID (Drug) $74.15
- XELJANZ (Drug) $61.37
- OCALIVA (Drug) $58.98
- REMICADE (Biological) $42.98
- DUPIXENT (Biological) $42.82
- GI GENIUS (Device) $42.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Knoxville
Dr. Carlos Rollhauser, Md, MD
Gastroenterology — Payments: $213,612
Raj Narayani, Md, MD
Gastroenterology — Payments: $181,238
Meade Edmunds, Md, MD
Gastroenterology — Payments: $20,947
Charles O'connor, Md, MD
Gastroenterology — Payments: $19,665
Robert Pollack, Md, MD
Gastroenterology — Payments: $16,442
Jeffrey Brown, Md, MD
Gastroenterology — Payments: $16,002